RecallCheckr

Zydus Pharmaceuticals (USA) Inc recalls

31 recalls on record · FDA

Every recall we have on record for Zydus Pharmaceuticals (USA) Inc, compiled from federal safety data. Check the hazard, the remedy, and how serious each one is, and always confirm on the official notice.

Filter:
Health Serious

Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus…

CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc May 27, 2026
Read the recall
Health Serious

Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus…

CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc May 27, 2026
Read the recall
Health Serious

Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by:…

Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

Zydus Pharmaceuticals (USA) Inc Mar 18, 2026
Read the recall
Health Serious

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel…

Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

Zydus Pharmaceuticals (USA) Inc Jan 28, 2026
Read the recall
Health Moderate

traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by:…

Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

Zydus Pharmaceuticals (USA) Inc Jan 7, 2026
Read the recall
Health Serious

Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus…

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Zydus Pharmaceuticals (USA) Inc Oct 8, 2025
Read the recall
Health Serious

Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus…

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Zydus Pharmaceuticals (USA) Inc Oct 8, 2025
Read the recall
Health Serious

Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences…

Failed Impurity/Degradation Specifications

Zydus Pharmaceuticals (USA) Inc Sep 24, 2025
Read the recall
Health Serious

Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured…

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc Sep 17, 2025
Read the recall
Health Serious

Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 100-count bottle, Rx only, Manufactured…

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc Sep 17, 2025
Read the recall
Health Serious

Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only,…

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc Sep 17, 2025
Read the recall
Health Serious

Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle, Rx only, Manufactured…

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc Sep 17, 2025
Read the recall
Health Serious

Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle, Rx only,…

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc Sep 17, 2025
Read the recall
Health Serious

Chlorpromazine Hydrochloride Tablets, USP, 200 mg, 100-count bottle, Rx only,…

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc Sep 17, 2025
Read the recall
Health Serious

Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured…

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc Sep 17, 2025
Read the recall
Health Serious

Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel…

Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.

Zydus Pharmaceuticals (USA) Inc Jun 18, 2025
Read the recall
Health Serious

Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose…

Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.

Zydus Pharmaceuticals (USA) Inc May 28, 2025
Read the recall
Health Serious

chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles,…

CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

Zydus Pharmaceuticals (USA) Inc Apr 16, 2025
Read the recall
Health Serious

Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd,…

Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.

Zydus Pharmaceuticals (USA) Inc Apr 16, 2025
Read the recall
Health Moderate

Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets,…

Labeling: Not Elsewhere Classified - Wrong NDC number

Zydus Pharmaceuticals (USA) Inc Dec 11, 2024
Read the recall
Health Serious

Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count…

Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.

Zydus Pharmaceuticals (USA) Inc Jul 31, 2024
Read the recall
Health Serious

Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only,…

Presence of particulate matter: glass

Zydus Pharmaceuticals (USA) Inc Jul 24, 2024
Read the recall
Health Moderate

Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL…

Cross contamination with other products.

Zydus Pharmaceuticals (USA) Inc Jul 17, 2024
Read the recall
Health Moderate

Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL), 5 x 4 mL Single-Dose Vial…

Cross contamination with other products.

Zydus Pharmaceuticals (USA) Inc Jul 17, 2024
Read the recall
Health Moderate

Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by:…

Cross contamination with other products

Zydus Pharmaceuticals (USA) Inc Jul 17, 2024
Read the recall
Health Moderate

Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by:…

Failed Impurities/Degradation Specifications.

Zydus Pharmaceuticals (USA) Inc Jun 12, 2024
Read the recall
Health Serious

Oxybutynin Chloride Extended-Release Tablet USP, 5 mg, 100 count bottles, Rx Only,…

Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.

Zydus Pharmaceuticals (USA) Inc Nov 15, 2023
Read the recall
Health Serious

Oxybutynin Chloride Extended-Release Tablet USP, 15 mg, 100 count bottles, Rx Only,…

Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.

Zydus Pharmaceuticals (USA) Inc Nov 15, 2023
Read the recall
Health Serious

Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 68382-256-01)…

Failed Dissolution Specifications

Zydus Pharmaceuticals (USA) Inc Oct 11, 2023
Read the recall
Health Moderate

Colchicine Tablets, USP 0.6 mg, Rx Only, a) 30 tablets per bottle, NDC 16714-0039-01, b)…

Failed Impurities/Degradation Specifications: An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine.

Zydus Pharmaceuticals (USA) Inc Mar 22, 2023
Read the recall
Health Serious

Fulvestrant Injection 250mg/5mL (50 mg/mL), Contains 2 Single-Dose Prefilled Syringes, Rx…

Failed Impurities/Degradation Specifications

Zydus Pharmaceuticals (USA) Inc Aug 24, 2022
Read the recall